Patent Review Method Should Consider Public Interest Factors - Torricelli

Review mechanisms for the extension of "pipeline" drug patents should take into account public interest factors, Sen. Torricelli (D-N.J.) told a House Judiciary/Intellectual Property Subcommittee hearing July 1.